PD-L1 tested non-small cell lung carcinoma tissue microarray, it is suitable for tumor immunotherapy, single core per case. Pathology grade, TNM Classification, and Clinical Stages and PD-L1 (Sp263) information available. Replacing LC04.
3 cases PD-L1(Sp263) are positive and 1 case is negative
Positive:
- 1 case of adenocarcinoma
- 2 cases of squamous cell carcinoma
Negative:
- 1 case of squamous cell carcinoma
Catalogue No |
RLN04a |
Description |
PD-L1 tested non-small cell lung carcinoma tissue microarray, it is suitable for tumor immunotherapy, single core per case. Pathology grade, TNM Classification, and Clinical Stages and PD-L1 (Sp263) information available. Replacing LC04. |
Species |
Human |
Fixative |
Formalin |
Total Cases |
4 |
Total Cores |
4 |
Core Diameter |
2 mm |
Section Thickness |
5 µm |
Storage |
Short term RT; Long term 4ºC |
Usage |
For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | Sp263 |
---|
1 | A1 | 57 | M | Lung | Adenocarcinoma | 1 | T2N1M0 | IIA | Malignant | TC≥25% |
2 | A2 | 63 | M | Lung | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant | TC≥85% |
3 | A3 | 62 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | TC≥25% |
4 | A4 | 50 | F | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | - |